<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20240630062285N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2024-07-05</date_registration>
      <primary_sponsor>Tehran University of Medical Sciences</primary_sponsor>
      <public_title>Effect of early oral feeding on consequences of Cesarean section</public_title>
      <acronym></acronym>
      <scientific_title>Investigating the effect of early oral feeding on consequences and complications of elective Cesarean section</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2024-07-01</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>120</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/77686</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive, Randomization description: The participants were randomly assigned to groups using a computer-generated random number sequence with a block size of four. The generated identifiers were placed in sealed envelopes by a statistician and attached to the doctor's order sheets. The envelopes were opened after surgery, and the information was manually recorded onto the clinicians' order sheets. Nurses provided oral feedings to the participants. The analyzer was blinded to the group assignments, but the participants and nurses were not, Blinding description: The participants were randomly assigned to groups using a computer-generated random number sequence with a block size of four. The generated identifiers were placed in sealed envelopes by a statistician and attached to the doctor's order sheets. The envelopes were opened after surgery, and the information was manually recorded onto the clinicians' order sheets. Nurses provided oral feedings to the participants. The analyzer was blinded to the group assignments, but the participants and nurses were not. The same person who distributed the informed consent and performed the analysis was the blinded assessor.</study_design>
      <phase>N/A</phase>
      <hc_freetext>post operative ileus.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Patients who experience early oral feeding 4 hours after cesarean delivery. Patients undergo elective cesarean section in the morning. Initiation of feeding 4 hours after surgery with warm tea followed by hospital diet. Patients are advised to avoid raw fruits, milk, and legumes for 12 hours after the operation. Intervention 2: Control group: Patients who experience early oral feeding 8 hours after cesarean delivery. Patients undergo elective cesarean section in the morning. Initiation of feeding 8 hours after surgery with warm tea followed by hospital diet. Patients are advised to avoid raw fruits, milk, and legumes for 12 hours after the operation.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
After completing the study, the results of the study will be published in the form of a scientific article, and the data will be accessible through correspondence with the corresponding author.

When:
The possibility of accessing the data will be available after the publication of the study results in scientific journals, which will be around 9 months after the completion of the study.

To whom:
The data will be made available to researchers and decision-makers in the healthcare system.

Conditions:
The data will be made available if the purpose of the research is to improve healthcare for patients, while maintaining the privacy of the participants.

Where to obtain:
Contact the corresponding author

How to obtain:
The process of accessing the data is through correspondence by email or telephone contact with the corresponding author.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Arian Faramarzinia</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Baharloo hospital, Behdari street, Rahahan square</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1594654813</zip>
        <telephone>+98 21 5565 8500</telephone>
        <email>Arianfaramarzinia79@gmail.com</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Arian Faramarzinia</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Baharloo Hospital., Behdari Street., Rahahan Square</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1594654813</zip>
        <telephone>+98 21 5565 8500</telephone>
        <email>َArianfaramarzinia79@gmail.com</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Pregnant women at or beyond 37 weeks of gestation who are candidates for elective cesarean section under spinal anesthesia</inclusion_criteria>
      <agemin>no limit</agemin>
      <agemax>no limit</agemax>
      <gender>Female</gender>
      <exclusion_criteria>Patients who experienced severe adhesions during their cesarean section                                                                                   Procedure duration was longer than 45 minutes                   Women with underlying gastrointestinal conditions such as inflammatory bowel disease                                                                      Patients with emergency delivery indications (e.g., placenta previa, premature rupture of membranes, etc.)                                                    Patients who, for any reason, including contraindications to general anesthesia or spinal anesthesia, or personal preference, did not receive spinal anesthesia during their cesarean section      Women who experienced postoperative hemorrhage</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>K56.7</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Ileus, unspecified</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Patients who experience early oral feeding 4 hours after cesarean delivery. Patients undergo elective cesarean section in the morning. Initiation of feeding 4 hours after surgery with warm tea followed by hospital diet. Patients are advised to avoid raw fruits, milk, and legumes for 12 hours after the operation.</i_keyword>
      <i_keyword>Control group: Patients who experience early oral feeding 8 hours after cesarean delivery. Patients undergo elective cesarean section in the morning. Initiation of feeding 8 hours after surgery with warm tea followed by hospital diet. Patients are advised to avoid raw fruits, milk, and legumes for 12 hours after the operation.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Time to pass flatus post cesarean. Timepoint: Every 6 hours until the patient experiences first flatus passage. Method of measurement: Patient self-report and documentation in the medical record.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Time to first bowel movement after cesarean section. Timepoint: Every 6 hours until the patient experiences first bowel movement. Method of measurement: Patient self-report and documentation in the medical record.</sec_outcome>
      <sec_outcome>Maternal satisfaction with hospital stay. Timepoint: At the end of hospitalization. Method of measurement: Visual Analogue Scale.</sec_outcome>
      <sec_outcome>Abdominal cramp. Timepoint: Every 6 hours throughout the hospital stay. Method of measurement: Patient self-report and physician examination using a checklist.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Tehran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2023-02-07</approval_date>
        <contact_name>Ethics committee of Tehran University of Medical Sciences</contact_name>
        <contact_address>Baharloo hospital, Behdari street., Rahahan square. Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
